Blood tests    (DrugBank: -)

2 diseases
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis1
263Cerebrotendinous xanthomatosis1

46. Malignant rheumatoid arthritis    [ 4,183 clinical trials,   2,538 drugs,   (DrugBank: 401 drugs),   183 drug target genes,   219 drug target pathways]
Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 4,183 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04584541
(ClinicalTrials.gov)
June 11, 202010/6/2020SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory RheumatismStudy of the Viral Load and Humoral and Cellular B and T Responses in Patients With Rheumatoid Arthritis and Spondyloarthritis Under Immunosuppressive TreatmentsSpondyloarthritis;Rheumatoid Arthritis;Covid19Biological: blood tests;Biological: Nasopharyngeal swabs;Biological: StoolsAssistance Publique - Hôpitaux de ParisNULLRecruiting18 YearsN/AAll150N/AFrance

263. Cerebrotendinous xanthomatosis    [ 5 clinical trials,   10 drugs,   (DrugBank: 2 drugs),   2 drug target genes,   4 drug target pathways]
Searched query = "Cerebrotendinous xanthomatosis", "27-hydroxylase deficiency", "CYP27 deficiency"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 5 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01613898
(ClinicalTrials.gov)
August 201022/5/2012Evaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous XanthomatosisEvaluation of Carotid IMT and Atherogenic Risk Factors in Patients With Cerebrotendinous XanthomatosisCerebrotendinous Xanthomatosis (CTX)Biological: Blood testsSheba Medical CenterNULLRecruiting10 YearsN/ABoth17N/AIsrael